The nature of the cardiac myxoma

International Journal of Cardiology

Volumn 57, Issue 3, 1996, Pages 211-216

  Suvarna, S K ^a   Royds, J A ^b  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

cardiac myxoma; hamartoma; immunohistochemistry; oncogene; proliferation index; tumour suppressor gene

Indexed keywords

ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; GENE EXPRESSION; HEART MYXOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ONCOGENE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADULT; CELL DIVISION; FEMALE; HEART NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; MONOMERIC GTP-BINDING PROTEINS; MYXOMA; NUCLEOSIDE-DIPHOSPHATE KINASE; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-BCL-2; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030582718     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(96)02827-6     Document Type: Article

References (35)

1. [1] McAllister HA, Fenoglio JJ. Tumors of the cardiovascular system. Washington DC: Armed Forces Institute of Pathology, 1996; 21-46.
2. [2] Rosai J. Ackerman's Surgical Pathology, 7th ed. St. Louis: CV Mosby, 1996; 2182-2184.
3. [3] Carney JA. Differences between nonfamilial and familial cardiac myxoma. Am J Surg Pathol 1985; 9: 53-55.
4. [4] McCarthy PM, Piehler JM, Schaff HV, Pluth JR, Orszulak TA, Vidaillet HJ et al. The significance of multiple, recurrent, and 'complex' cardiac myxomas. J Thorac Cardiovasc Surg 1986; 91: 389-396.
5. [5] Carney JA, Hruska LS, Beauchamp GD, Gordon H. Dominant inheritance of the complex of myxomas, spotty pigmentation and endocrine overactivity. Mayo Clin Proc 1986; 61: 165-172.
6. [6] Ferrans VJ, Roberts WC. Structural features of cardiac myxomas. Hum Pathol 1973; 4: 111-146.
7. [7] Feldman PS, Horvath E, Kovaks K. An ultrastructural study of 7 cardiac myxomas. Cancer 1977; 40: 2216-2232.
8. [8] Wold LE, Lie JT. Scanning electron microscopy of intracardiac myxoma. Mayo Clin Proc 1981; 56: 198-200.
9. [9] Lie JT. The identity and histogenesis of cardiac myxomas. Arch Pathol Lab Med 1989; 113: 724-726.
10. [10] Landon G, Ordonez NG, Guarda LA. Cardiac myxomas. An immunohistochemical study using endothelial, histiocytic and smooth muscle markers. Arch Pathol Lab Med 1986; 110: 116-120.
11. [11] Krikler DM, Rode J, Davies MJ, Woolf N, Moss E. Atrial myxoma: a tumour in search of its origins. Br Heart J 1992; 67: 89-91.
12. [12] Salyer WR, Page DL, Hutchins GM. The development of cardiac myxomas and papillary endocardial lesions from mural thrombus. Am Heart J 1975; 89: 4-17.
13. [13] Cotran RS, Kumar V, Robbins SL. Robbins Pathologic Basis of Disease, 4th ed. Philadelphia: WB Saunders, 1989; 239-305.
14. [14] Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C et al. Immunobiochemical and molecular biologic characterisation of the cell proliferation-associated nuclear that is defined by monoclonal antibody Ki67. Am J Pathol 1991; 138: 867-873.
15. [15] McCormick D, Yu C, Hobbs C, Hall PA. The relevance of antibody concentration to the immunohistochemical quantification of cell proliferation associated antigens. Histopathology 1993; 22: 543-547.
16. [16] McCormick D, Hall PA. The complexities of proliferating cell nuclear antigen. Histopathology 1992; 21: 591-594.
17. [17] Wynford-Thomas D. p53 in tumour pathology: can we trust immunocytochemistry? J Pathol 1992; 166: 329-330.
18. [18] Canman CE, Kastan MB. Induction of apoptosis by tumour suppressor genes and oncogenes. Cancer Biol 1995; 6: 17-25.
19. [19] Royds JA, Webley K, Karcioglu ZA, Parsons MA. Apoptosis-related gene expression in retinoblastomas. Br J Cancer, 1996; 44: 73S.
20. [20] Jacks T, Fazeli A, Schmitt AM, Bronson RT, Goodell MA, Weinberg RA. Effects of an Rb mutation in the mouse. Nature 1992; 359: 295-300.
21. [21] Tsujimoto Y, Ikegaki N, Croce CM. Characterisation of the protein product of bcl-2, the gene involved in human follicular lymphoma. Oncogene 1987; 2: 3-7.
22. [22] Nathan B, Anbazhagan R, Dyer M, Ebbs SR, Jayatilake H, Gusterson BA. Expression of bcl-2-like reactivity in the normal breast and in breast cancer. The Breast 1992; 2: 134-137.
23. [23] Leone A, Flatow U, VanHoutte K, Steeg PS. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on the tumor metastatic potential, colonisation and enzymic activity. Oncogene 1993; 8: 2325-2333.
24. [24] Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA, Sobel ME. Evidence for a novel gene associated with low metastatic potential. J Natl Cancer Inst 1988; 80: 200-204.
25. [25] Royds JA, Stephenson TJ, Rees RC, Shorthouse AJ, Silcocks PB. nm23 product expression in ductal in situ and invasive human breast carcinoma. J Natl Cancer Inst 1993; 85: 727-731.
26. [26] Stephenson TJ, Royds JA, Silcocks PB, Brammer HJ, Shorthouse AJ, Underwood JCE. Diagnostic association of p53 immunostaining in fine needle aspiration cytology of the breast. Cytopathology 1994; 5: 145-153.
27. [27] Tanimura A, Masatomo K, Nagayama N, Tanaka S, Kosuga K. Cardiac myxoma. Morphological histochemical and tissue culture studies. Hum Pathol 1988; 19: 316-322.
28. [28] Gebode F, Kerth WJ, Hill JD. Surgical management of tumors of the heart. Surgery 1961; 61: 94-101.
29. [29] Read RC, White HJ, Murphy ML, Williams D, Sun CN, Flanagan WH. The malignant potentiality of left atrial myxoma. J Thorac Cardiovasc Surg 1974; 68: 857-868.
30. [30] Richkind KE, Wason D, Vidaillet HJ. Cardiac myxoma characterized by clonal telomeric association. Genes Chromosomes Cancer 1994; 9: 68-71.
31. [31] Dewald GW, Dahl RJ, Spurbek JL, Carney JA, Gordon H. Chromosomally abnormal clones and nonrandum telomeric translocations in cardiac myxomas. Mayo Clin Proc 1987; 62: 558-567.
32. [32] McCarthy PM, Schaff HV, Winkler HZ, Lieber MM, Carney JA. Deoxyribonucleic acid ploidy pattern of cardiac myxomas. J Thorac Cardiovasc Surg 1989; 98: 1083-1086.
33. [33] Kotylo PK, Kennedy JE, Waller BF, Sample RB. DNA analysis of atrial myxomas. Chest 1991; 99: 1203-1207.
34. [34] Nolan J, Carder PJ, Bloomfield P. Atrial myxoma: tumour or trauma? Br Heart J 1992; 67: 406-408.
35. [35] Fletcher CD (Ed). Diagnostic Histopathology of Tumors. Edinburgh: Churchill Livingstone, 1995; 7-41.